vMCO-I

· Nanoscope Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for vMCO-I, covering 2021-06-09 to 2025-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection